New cymbalta contraindication

Duloxetine has been associated with an increase in blood pressure and cases of hypertensive crisis have been reported, especially in patients with pre-existing hypertension.

Therefore, Cymbalta (duloxetine hydrochloride) is now contraindicated in patients with uncontrolled hypertension. For patients who experience a sustained increase in blood pressure while receiving duloxetine, either a dose reduction or gradual discontinuation should be considered. In patients with known hypertension and/or other cardiac disease, blood pressure monitoring is recommended, especially during the first month of treatment.

Further information: Lilly 01256 315000

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Gluten-free prescribing restricted to bread and mixes

Gluten-free prescribing restricted to bread and mixes

GPs in England are no longer able to prescribe gluten-free...

New vitamin D deficiency thresholds recommended

New vitamin D deficiency thresholds recommended

The National Osteoporosis Society (NOS) has updated...

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors may be linked to a doubling in the...

New MIMS table helps prescribers choose asthma inhalers

New MIMS table helps prescribers choose asthma inhalers

Prescribers can now turn to a handy MIMS comparison...